Greystone Associates Analyzes Demand Factors and Market Trends Fueling Growth of Prefilled Syringes
As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug marketers. One result is a worldwide market for prefilled syringes that reached just under two billion units in 2008 and is growing at fourteen percent annually.
“The growth of prefillable syringes has been aided by innovations in the materials of construction, automated aseptic filling technology, and the availability of options caregivers have come to expect from traditional syringes such as a choice of needle configurations,” explains George Perros, Greystone Associates Managing Director. “Other factors that make prefillable syringes attractive for a growing number of injectable drugs and indications include compatibility with existing needle shielding systems, and the availability of advanced barrier films and coatings for syringes molded of engineered plastics such as the cyclic olefins.”
Over the next four years, the growth of prefilled syringes will be driven by increased penetration into existing therapeutic drug segments, as well as entry into new therapeutic areas. Geographically, while the North American and European regions will continue to dominate in terms of total units, growth in Asia will be a factor in keeping total annual unit growth in double digits.
More information on the growth of prefilled syringes can be found in a comprehensive report, researched and prepared by Greystone Associates. Prefilled Syringes: Drugs, Devices and Delivery Strategies examines specialty injectable drug trend data and provides analysis and forecasts for injectable drug therapeutic sectors.
More information is available at www.greystoneassociates.org .
About Greystone
Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
Source: Greystone Associates
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
